Dexcom Encourages Jereme Sylvain to Chief Economic Officer
SAN DIEGO–(Company WIRE)–DexCom, Inc. (NASDAQ: DXCM), the world-wide leader in real-time continual glucose monitoring, currently introduced the advertising of Jereme Sylvain to the function of Govt Vice President and Chief Financial Officer. In his expanded function, Mr. Sylvain will think responsibility for Dexcom’s whole finance group and report to Quentin Blackford, Chief Running Officer.
Mr. Sylvain is an completed government with a lot more than 20 yrs of expertise in corporate finance and accounting roles at primary clinical technological innovation firms. Since becoming a member of Dexcom, Mr. Sylvain has played an instrumental job in the development of the company’s world-wide finance organization. Most lately, he has served as Dexcom’s Senior Vice President, Finance and Chief Accounting Officer considering the fact that March 2020.
“Since signing up for Dexcom, Jereme has consistently demonstrated his ability to support the firm travel efficient scale and procedures even though also strengthening the finance team,” mentioned Kevin Sayer, Chairman, President and Main Executive Officer at Dexcom. “Jereme’s expanded management will enable Quentin to go on to execute on our plans to scale the business. With the current institution of Dexcom Ventures, Quentin will also now think duty for our technique and corporate advancement features in addition to his current COO duties.”
“I am honored to think the CFO position and continue on the good work remaining innovative by the Dexcom management team and focused personnel,” claimed Mr. Sylvain. “I feel in our mission to bring Dexcom CGM technology to quite a few additional folks all through the globe, driving greater wellness and financial results for our prospects and generating potent benefit generation for our shareholders.”
About Jereme Sylvain
Mr. Sylvain has served as our Senior Vice President, Finance and Main Accounting Officer considering the fact that March 2020, and joined DexCom in September 2018 as our Vice President, Finance and Company Controller. Prior to signing up for Dexcom, Mr. Sylvain held numerous positions at NuVasive, Inc., like Vice President, Company Controller and Chief Accounting Officer from August 2016 to September 2018 and Vice President, Corporate Controller from March 2014 to August 2016. Prior to becoming a member of NuVasive, Mr. Sylvain held the job of Senior Director, Finance with Thermo Fisher Scientific, the place he was liable for worldwide accounting for the everyday living sciences remedies group. Mr. Sylvain joined Thermo Fisher Scientific in February 2014, following its acquisition of Life Technologies Corporation. From July 2007 to February 2014, Mr. Sylvain held numerous finance and accounting roles at Daily life Technologies and its predecessor, Invitrogen Company. Prior to joining Invitrogen, Mr. Sylvain labored for the community accounting firm Ernst & Young LLP.
Mr. Sylvain obtained his Accredited General public Accounting license right after getting a B.A. in Finance from Arizona Point out College and a M.S. in Accountancy from the College of Notre Dame.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is creating and promoting continuous glucose monitoring techniques for ambulatory use by people with diabetes and by healthcare providers for the therapy of folks with diabetic issues.
